Immuron posts Emerging Growth Conference presentation

Immuron Limited furnished a Form 6-K as a foreign private issuer for October 2025.

Accepted by SEC EDGAR 10/22/2025 - 09:52 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Immuron Limited furnished a Form 6-K as a foreign private issuer for October 2025. The company attached as Exhibit 99.1 an Emerging Growth Conference Presentation that had been announced on the Australian Securities Exchange on October 23, 2025.

The company notes that this Form 6-K, including its exhibit, is furnished rather than filed under U.S. securities laws and will not be incorporated into other U.S. securities filings unless specifically referenced.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Immuron Limited (IMRN) submit in this Form 6-K?

Immuron Limited submitted a Form 6-K furnishing an Emerging Growth Conference Presentation as Exhibit 99.1. The presentation was previously announced on the Australian Securities Exchange on October 23, 2025, and is now made available to U.S. investors through this report.

What is included as Exhibit 99.1 for Immuron Limited (IMRN)?

Exhibit 99.1 consists of an Emerging Growth Conference Presentation by Immuron Limited. This exhibit accompanies the Form 6-K to provide the same information that was released on the Australian Securities Exchange on October 23, 2025, to the U.S. market.

Is Immuron Limited’s (IMRN) Form 6-K considered filed under the Exchange Act?

The Form 6-K and its exhibit are expressly described as furnished, not filed, under the Exchange Act. This means they are provided for informational purposes and have different legal status than documents formally filed with the U.S. Securities and Exchange Commission.

Will Immuron Limited (IMRN) automatically incorporate this 6-K into other SEC filings?

The company states this Form 6-K will not be incorporated by reference into other U.S. securities filings. It will only be incorporated if a future filing specifically refers to this report or its exhibit, limiting its automatic legal integration.

Who signed Immuron Limited’s (IMRN) October 23, 2025 Form 6-K?

The Form 6-K was signed on behalf of Immuron Limited by Company Secretary Phillip Hains. The signature confirms the company’s authorization of the furnished materials and their submission as a report of a foreign private issuer on October 23, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the Month of October 2025

Commission File Number: 001-38104

IMMURON LIMITED

(Name of Registrant)

Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒       Form 40-F ☐

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐       No ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-

IMMURON LIMITED

EXPLANATORY NOTE

Immuron Limited (the “Company”) published one announcement (the “Public Notices”) to the Australian Securities Exchange on October 23, 2025 titled:

-  Emerging Growth Conference Presentation

A copy of the Public Notice is attached as an exhibit to this report on Form 6-K.

This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

1 

EXHIBITS

Exhibit Number		Description
99.1		Emerging Growth Conference Presentation

2 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	IMMURON LIMITED
Date: October 23, 2025	By:	/s/ Phillip Hains
		Phillip Hains
		Company Secretary

3